FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis. (Q51168093)

31 March 2018

title

FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis. (English)

1 reference

31 March 2018

5

Lars Andreas Akslen

1 reference

31 March 2018

1

Marit Valla

1 reference

31 March 2018

Anna Mary Bofin

8

object named as

Anna Mary Bofin

1 reference

31 March 2018

Monica Jernberg Engstrøm

2

object named as

Monica Jernberg Engstrøm

1 reference

31 March 2018

Borgny Ytterhus

3

object named as

Borgny Ytterhus

1 reference

31 March 2018

author name string

Åse Kristin Skain Hansen

4

1 reference

31 March 2018

Lars Johan Vatten

6

1 reference

31 March 2018

Signe Opdahl

7

1 reference

31 March 2018

language of work or name

English

0 references

publication date

25 January 2017

1 reference

31 March 2018

Breast Cancer Research and Treatment

published in

1 reference

31 March 2018

volume

162

1 reference

31 March 2018

issue

2

1 reference

31 March 2018

page(s)

243-253

1 reference

31 March 2018

Hallmarks of Cancer: The Next Generation

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Fallibility in estimating direct effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Gene amplification in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Updated UK Recommendations for HER2 assessment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Validation of tissue microarray technology in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Fgd5 identifies hematopoietic stem cells in the murine bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Facio-genital dysplasia-5 regulates matrix adhesion and survival of human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

Comparative allelotyping epithelial tumors of the short arm of human chromosome 3 in of four different types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4125-8

10.1007/S10549-017-4125-8

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018